ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

ACR Convergence 2024

November 14-19, 2024. Washington, DC.

View by Number View by Title View Sessions

Saturday, November 16, 2024

9:15AM-10:45AM
Abstract Number: 0774
A Multicenter, Randomized, Controlled Trial to Evaluate the Effects of Low-dose Glucocorticoids Compared to Stopping Glucocorticoids to Maintain Remission of Granulomatosis with Polyangiitis: The TAPIR Trial
Plenary I
9:15AM-10:45AM
Abstract Number: 0773
Anti-Citrullinated Histone Antibody CIT-013 Targets NETs in Inflamed Joints and Halts NET-mediated Joint Deterioration
Plenary I
9:15AM-10:45AM
Abstract Number: 0771
Arid5b Controls Pathologic Inflammatory versus Invasive Fibroblast Behavior
Plenary I
9:15AM-10:45AM
Abstract Number: 0770
Efficacy and Safety of Upadacitinib in Patients with Giant Cell Arteritis (SELECT-GCA): A Double-Blind, Randomized Controlled Phase 3 Trial
Plenary I
9:15AM-10:45AM
Abstract Number: 0772
Global Recruiting Patterns Are Associated with Placebo Response Rates in Clinical Trials of Psoriatic Arthritis
Plenary I
10:30AM-12:30PM
Abstract Number: 0255
“Rheum” to Improve: Have Patients Attending the Young Adult Systemic Erythematosus (YASLE) Clinic Received All Appropriate Vaccinations? A Quality Improvement Initiative
Infection-related Rheumatic Disease Poster
10:30AM-12:30PM
Abstract Number: 0574
14-3-3 Eta (η) Auto-Antibody as a Diagnostic Marker in Axial Spondyloarthritis: A Longitudinal Study
SpA Including PsA – Diagnosis, Manifestations, & Outcomes Poster I
10:30AM-12:30PM
Abstract Number: 0506
24-week, Post-Marketing Surveillance Analysis of Upadacitinib in Japanese Patients with Rheumatoid Arthritis: The 2024 Interim Report
RA – Treatment Poster I
10:30AM-12:30PM
Abstract Number: 0640
7000-Plex Proteomic Screen of Urine for Flare Monitoring and Treatment Response Biomarkers in Active Lupus Nephritis
SLE – Diagnosis, Manifestations, & Outcomes Poster I
10:30AM-12:30PM
Abstract Number: 0223
A Comparative Study of Difficult-to-Treat vs Non-Difficult-to-Treat Psoriatic Arthritis for Disease Burden and Comorbidities: An Ultrasound Study
Imaging of Rheumatic Diseases Poster I: Inflammatory Arthritis
10:30AM-12:30PM
Abstract Number: 0492
A Machine Learning Model for the Early Identification of Rheumatoid Arthritis: Development and Validation
RA – Diagnosis, Manifestations, & Outcomes Poster I
10:30AM-12:30PM
Abstract Number: 0760
A Macrophage-smooth Muscle Cell Axis Influences Vascular Remodeling Through Activation of the EGFR Pathway in Giant Cell Arteritis
Vasculitis – Non-ANCA-Associated & Related Disorders Poster I
10:30AM-12:30PM
Abstract Number: 0174
A Nationwide Analysis of Gender and Racial Disparities in Patients with Systemic Sclerosis and Acute Coronary Syndrome
Epidemiology & Public Health Poster I
10:30AM-12:30PM
Abstract Number: 0092
A New Generation Mesenchymal Stromal Cell (MSC)-based Cell Therapy Using Design of Experiments Halts Pristane Induced Glomerulosclerosis
SLE – Animal Models Poster
10:30AM-12:30PM
Abstract Number: 0019
A Novel Product Candidate (CPTX2309) for In Vivo mRNA Engineering of Anti-CD19 CAR T Cells Utilizing Novel CD8-Targeted Lipid Nanoparticles
B Cell Biology & Targets in Autoimmune & Inflammatory Disease Poster
  • 1
  • 2
  • 3
  • …
  • 60
  • Next Page

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology